[1] 赵敬军,张正华,刘维迭,等.特比奈芬(兰美抒)在中国应用6年情况回顾[J].临床皮肤科杂志(J Clin Dermato1),2001,30(4):272-5. [2] 刘美琳,刘卫平,袁安,等.特比奈芬治疗108例甲真菌病的疗效及安全性评价[J] 中国麻风皮肤病杂志(Chin J Lepr Skin Dis),2003,19(2):195. [3] Faergemann J, Zehender H, Denouel J, et al. Levels of terhinafine in plasma, stratum comeum, dermisepidermis ( without stratum comeum),sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks [J]. Acta Derm Venereol, 1993,73(4): 305-9. [4] Halfour JA, Fanlds D. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses [J]. Drugs, 1992, 43(2): 259-84. [5] Gupta Ak, Scher RK, De Doncker P. Current management ofonychomycosis: an overview[J]. Dermatol Clin, 1997, 15: 121-35. [6] Chiritescu MM, Chiritescu ME, Scher RK. Newer systemic antifungal drugs for the treatment of onychomycosis [J]. Clin Podiatr Med Surg, 1996, 13: 741-58. |